Recently, in a population-based study of smokers offered CXR screening we confirmed that the volunteer effect is characterized by significantly higher LC mortality risk in self-selected participants compared to nonparticipants (risk ratio 1.40; 95% CI, 1.03 1.91) [ 5].
Population based studies showed that lung cancer in non-smokers occurs preferentially in women with almost 20% of non-smoker lung cancer diagnosed in women versus 2.5% in men [ 2].
Although there is no doubt that active smoking is the major cause of lung cancer, the contribution of other possible factors, including environmental tobacco or wood smoke, human papilloma virus, radon, occupational exposures, and genetic susceptibility, is highly likely, based on studies of never-smokers with non small-cell lunon small-cell
Examining genetic influences within a group of moderate to heavy smokers who were sufficiently motivated to quit that they chose to participate in a randomized trial might be expected to enhance our ability to isolate and identify genetic effects on smoking cessation (independent of psychosocial factors related to motivation), relative to studies based on comparisons of smokers and nonsmokers.
Goodman and Valberg conceded that no study of smokers had ever shown the link, but said such studies were statistically weak because they didn't include enough smokers.
Most of this information is based on studies of non-AI/AN smokers.
Based on a study of 13,945 Icelandic smokers, deCODE's researchers showed that having a T in the appropriate part of the gene correlates very strongly indeed with being a heavy smoker.
The actual levels of SHS exposure were a potentially important issue in the OSHA rule-making because, at the time, risk estimates for lung cancer were based on studies of non-smoking spouses married to smokers.
Three years later, a study of 200,000 smokers by the American Cancer Society showed that smokers had a 68percentt higher mortality rate than nonsmokers.
It is based on an opportunistic sample of smokers who voluntarily decided to take part in the study.
The baseline demographic and clinical characteristics of participants in each of the study groups (non-smokers, smokers without COPD, and smokers with COPD) are shown in Table 1.
